ロード中...
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
BACKGROUND: Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. METHODS: This was an open-label, multicentre, randomized c...
保存先:
| 出版年: | J Antimicrob Chemother |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7454592/ https://ncbi.nlm.nih.gov/pubmed/32812039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa334 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|